COVID Antibody Drugs Gaining Ground
(MedPage Today) -- While monoclonal antibody therapy options for COVID-19 are growing, there are still substantial hurdles to clinical uptake, despite improvements.
Eli Lilly's bamlanivimab became the first monoclonal antibody drug for COVID-19...
Read more »